Paper Details

  1. Home
  2. Paper Details

Can we predict short-term side effects of methylphenidate immediate-release?

Author: DedeogluCeyda, KarabekirogluKoray, YazganYanki M

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

In children and adolescents with ADHD, methylphenidate (MPH-IR) treatment led to a significant increase in loss of appetite, but a decrease in irritability, proneness to cry, anxiety, nail biting, and euphoria.
Paper Details　
Original Abstract of the Article :
Objective. In children and adolescents who were prescribed immediate-release methylphenidate (MPH-IR) for the first time, we aimed to investigate the effect of gender, psychiatric co-morbidity and the baseline severity of clinical symptoms on the short-term side-effects of the medication. Method. In...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/13651500701435954

データ提供：米国国立医学図書館（NLM）

Predicting Methylphenidate's Short-Term Side Effects

Understanding the potential side effects of medications is crucial for making informed decisions about treatment. This research focuses on the short-term side effects of methylphenidate (MPH-IR), a medication commonly prescribed for attention deficit hyperactivity disorder (ADHD).

Co-morbidity May Predict More Severe Side Effects

The study analyzed data from 90 children and adolescents who were newly prescribed MPH-IR. The results showed that while most side effects decreased over time, 'loss of appetite' increased. Interestingly, having a co-morbid diagnosis (other mental health conditions alongside ADHD) was associated with more severe side effects. This finding suggests that co-morbidity could be a factor to consider when assessing the potential risks and benefits of MPH-IR treatment.

Navigating Medication for ADHD

This research highlights the importance of careful monitoring for side effects, particularly in children and adolescents with ADHD. It also underscores the significance of considering the presence of co-morbidities when making treatment decisions. Open communication with healthcare providers is key to ensuring that the potential benefits of medication are weighed against the potential risks, leading to the best possible outcomes for individuals with ADHD.

Dr. Camel's Conclusion

Just as a desert traveler must carefully choose the right path to avoid hidden dangers, we must consider the potential side effects of medications, especially those used to treat complex conditions like ADHD. By understanding the factors that can influence side effects, we can navigate the treatment landscape with greater awareness and ensure the best possible outcomes for our patients.

Date :
  1. Date Completed 2014-06-12
  2. Date Revised 2014-06-11
Further Info :

Pubmed ID

24916497

DOI: Digital Object Identifier

10.1080/13651500701435954

Related Literature

Article Analysis
・Side Effects of methylphenidate
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.